Advisor Group Holdings, Inc. Prothena Corp Public LTD CO Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 547 shares of PRTA stock, worth $8,511. This represents 0.0% of its overall portfolio holdings.
Number of Shares
547
Previous 847
35.42%
Holding current value
$8,511
Previous $14,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding PRTA
# of Institutions
198Shares Held
44.5MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$180 Million7.5% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$79.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$60 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$57.3 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$34.8 Million0.44% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $730M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...